Showing results (1-10 of 10,334) with videos related to

Sort By:
Pageof 1,034
Internal Medicine (Tokyo, Japan)|November 1, 1992
Cushing's syndrome due to primary adrenocortical nodular dysplasia, cardiac myxomas, and spotty pigmentation, complicated by sarcoidosisH Akama, H Tanaka, H Yamada, et al.
Ryumachi. [Rheumatism]|August 1, 1995
[Methotrexate and salazosulfapyridine in the long-term treatment of rheumatoid arthritis]Y Ichikawa, T Shinozawa, T Yoshida, et al.
Ryumachi. [Rheumatism]|June 1, 1990
[Low dose methotrexate therapy in rheumatoid arthritis]T Shinozawa, H Akama, Y Matsushita, et al.
Ryumachi. [Rheumatism]|October 24, 1998
[Three cases of Munchausen's syndrome mimicking connective tissue diseases]S Takahashi, H Yamada, O Ishii, et al.
The Journal of Biological Chemistry|November 5, 1988
Monoclonal antibodies to the thyrotropin receptor bind to a 56-kDa subunit of the thyrotropin receptor and show heterogeneous bioactivitiesT Yoshida, Y Ichikawa, K Ito, et al.
Lupus|April 1, 1996
Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904T Yoshida, Y Ichikawa, T Tojo, et al.
Acta Endocrinologica|October 1, 1989
In vivo responsiveness to glucocorticoid correlated with glucocorticoid receptor content in peripheral blood leukocytes in normal humansH Tanaka, Y Ichikawa, H Akama, et al.
European Journal of Biochemistry|June 20, 1990
Purification and characterization of serine-glyoxylate aminotransferase from a serine-producing methylotroph, Hyphomicrobium methylovorum GM2Y Izumi, T Yoshida, H Yamada
The Journal of Rheumatology|October 1, 1996
Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritisT Yoshida, H Kameda, Y Ichikawa, et al.
Clinical Immunology and Immunopathology|September 1, 1990
CCA (disodium 4-chloro-2,2'-iminodibenzoate) inhibits progression of human T cell proliferation triggered by PHAK Katagiri, T Nakano, Y Sugawara, et al.
Pageof 1,034